GRF.MC GR

GRF.MC GRIFOLS S.A.

Healthcare · Drug Manufacturers - General

7 · Aceptable En riesgo

9.13

+0.42%

Sobre la empresa

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

0.88% 13.11% 0.08 14.96 0.61 10.36
52w 8.43 13.70

Perfil de dividendos

Frecuencia Anual Crecimiento (TTM) CAGR 3a -1.5%

Calendario de pagos

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Histórico de dividendos

9 10 13 14 15 16 17 18 19 20 21 25

Dividendo por acción por año

Deuda y apalancamiento

123.22% 2.47 0.78 Deuda total 9.7B EUR Efectivo total 702.0M EUR 1.7B EUR

Últimas cifras del balance publicadas.

seguido por 1

Regístrate para obtener un resumen con IA del dividendo de esta acción — y para seguirla en tu cartera.

Información, no asesoramiento financiero.

La información en Quantic se proporciona únicamente con fines informativos y educativos. Es de carácter general, no tiene en cuenta tu situación financiera personal y no constituye asesoramiento de inversión, financiero, fiscal o legal — ni una recomendación para comprar o vender ningún valor. Invertir conlleva riesgos, incluida la posible pérdida del capital; los resultados pasados no son un indicador fiable de los resultados futuros. Los datos de mercado provienen de proveedores terceros y pueden estar retrasados o ser inexactos. Antes de tomar cualquier decisión de inversión, considera tus objetivos, horizonte temporal, tolerancia al riesgo y diversificación, y consulta a un profesional financiero cualificado. Quantic no es un asesor financiero registrado ni un intermediario bursátil.

Quantic finance

Hecho con Elixir, Phoenix LiveView y Tailwind CSS

© 2026 Francesc Leveque · Aprender · Preguntas frecuentes